Kristin Ashford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kristin Ashford has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Andrea McCubbin
University of Kentucky College of Nursing, 751 Rose Street, #447, Lexington, KY 40536, United States
11 shared publicationsAmanda Wiggins
University of Kentucky College of Nursing, 751 Rose Street, #447, Lexington, KY 40536, United States
8 shared publicationsJanine Barnett
8 shared publicationsMary Kay Rayens
University of Kentucky College of Nursing, 751 Rose Street, #447, Lexington, KY 40536, United States
8 shared publicationsNiraj Chavan
Obstetrics and Gynecology, Maternal Fetal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky
7 shared publicationsAmanda T. Wiggins
6 shared publications
Latest Publications
- 4 August 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (5) , 767.e1-767.e10
Municipal smoke-free laws and preterm birth
- 4 August 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (5) , 767.e1-767.e10
Municipal smoke-free laws and preterm birth
- Open Access
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2885
Models of care for pregnant women with opioid use disorder: A multisite pilot study
Context: Pregnancy is an opportunity to engage women with opioid use disorder (OUD) in treatment. Models of care (MOC) for pregnant women with OUD vary widely, resulting in challenges for research. Objective: To enhance research capacity, we formed a multi-site collaborative and conducted a pilot study between 4 treatment clinics (UAMS, UK, UNM, UU) with dissimilar MOCs. Presented here are preliminary findings and comparisons of retention in treatment across MOCs. Study Design and Analysis: We conducted a multisite prospective study among pregnant with OUD who were in treatment for OUD during pregnancy. Data were collected during pregnancy at 2 time points. Descriptive statistics were computed. Setting: All 4 sites provided outpatient treatment for OUD among pregnant women; 2 sites provided integrated OUD treatment and prenatal care (Integrated; UU, UNM); 2 sites provided treatment of OUD in coordination with patients’ obstetric providers (Coordinated; UAMS, UK). Population: Eligibility included: > 18 years; gestational age > 22 weeks, receiving medication for OUD, English speaking, consented. Intervention/Instrument: We developed and tested an intake questionnaire administered to participants while waiting for clinic appointments, including social determinants of health (SDH). We collected mental health, comorbidities and demographic data. Outcome Measures: We compared retention in treatment operationalized as completion of questionnaire at second time point between Integrated vs. Coordinated treatment for OUD with prenatal care. We considered SDH as a possible confounder. Results: We reached our recruitment goal of 80 women with OUD who completed the initial questionnaire (UAMS=16, UK=20, UNM=20, UU=24). Mean age was 29; 66% were White, non-Hispanic; 79% graduated from high school; 24% were married; and 78% reported the father of the baby was involved in this pregnancy. Overall, demographic characteristics across sites were similar. Women in integrated treatment had higher proportions of any SDH compared to coordinated treatment (88% vs. 80%). Retention in study was lower for Integrated compared to Coordinated treatment (66% vs 72%), but similar when stratified by having any SDH. Conclusion: This small multisite pilot study provides a foundation of future research to study pregnant women with opioid use disorder. Comparisons between integrated versus coordinated care suggest similar retention rates when stratified by social determinants of health.
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2885
Open AccessModels of care for pregnant women with opioid use disorder: A multisite pilot study
Context: Pregnancy is an opportunity to engage women with opioid use disorder (OUD) in treatment. Models of care (MOC) for pregnant women with OUD vary widely, resulting in challenges for research. Objective: To enhance research capacity, we formed a multi-site collaborative and conducted a pilot study between 4 treatment clinics (UAMS, UK, UNM, UU) with dissimilar MOCs. Presented here are preliminary findings and comparisons of retention in treatment across MOCs. Study Design and Analysis: We conducted a multisite prospective study among pregnant with OUD who were in treatment for OUD during pregnancy. Data were collected during pregnancy at 2 time points. Descriptive statistics were computed. Setting: All 4 sites provided outpatient treatment for OUD among pregnant women; 2 sites provided integrated OUD treatment and prenatal care (Integrated; UU, UNM); 2 sites provided treatment of OUD in coordination with patients’ obstetric providers (Coordinated; UAMS, UK). Population: Eligibility included: > 18 years; gestational age > 22 weeks, receiving medication for OUD, English speaking, consented. Intervention/Instrument: We developed and tested an intake questionnaire administered to participants while waiting for clinic appointments, including social determinants of health (SDH). We collected mental health, comorbidities and demographic data. Outcome Measures: We compared retention in treatment operationalized as completion of questionnaire at second time point between Integrated vs. Coordinated treatment for OUD with prenatal care. We considered SDH as a possible confounder. Results: We reached our recruitment goal of 80 women with OUD who completed the initial questionnaire (UAMS=16, UK=20, UNM=20, UU=24). Mean age was 29; 66% were White, non-Hispanic; 79% graduated from high school; 24% were married; and 78% reported the father of the baby was involved in this pregnancy. Overall, demographic characteristics across sites were similar. Women in integrated treatment had higher proportions of any SDH compared to coordinated treatment (88% vs. 80%). Retention in study was lower for Integrated compared to Coordinated treatment (66% vs 72%), but similar when stratified by having any SDH. Conclusion: This small multisite pilot study provides a foundation of future research to study pregnant women with opioid use disorder. Comparisons between integrated versus coordinated care suggest similar retention rates when stratified by social determinants of health.
- 1 August 2021
- Published by Elsevier in Nursing for Women's Health
- Vol. 25 (4) , 257-263
Women’s Perceptions of Hospital-Based Breastfeeding Care and the Association With Exclusive Breastfeeding
- 1 August 2021
- Published by Elsevier in Nursing for Women's Health
- Vol. 25 (4) , 257-263
Women’s Perceptions of Hospital-Based Breastfeeding Care and the Association With Exclusive Breastfeeding
- 8 June 2020
- Published by Springer Publishing Company in Clinical Lactation
- Vol. 11 (2) , 65-73
Enabling Nurse Students to Achieve Their Breastfeeding Goals
Introduction: US workplace law requires employers to provide reasonable break time and space other than a bathroom for breastfeeding women to express their milk. However, this law does not include students in higher education institutions who choose to breastfeed, as students are typically not employed by their schools. The purpose of this report is to describe the joint efforts of faculty members and students to successfully operationalize a lactation room and develop college-specific lactation guidelines in a university in central Kentucky.Method: Students from a college of nursing (CON) participated in a survey (N = 135), of which 30% were parenting at that time (n = 41).Results: Responses from this subset were used to make the case to CON leadership and faculty to develop college-specific guidelines entitled, “Guidelines for Lactation Support,” which was included in students’ handbooks, and to the designated space for a lactation room in the CONbuilding.Discussion: The combined effort of faculty, administrators, and students was crucial to promotea breastfeeding-friendly environment in the CON.
- 8 June 2020
- Published by Springer Publishing Company in Clinical Lactation
- Vol. 11 (2) , 65-73
Enabling Nurse Students to Achieve Their Breastfeeding Goals
Introduction: US workplace law requires employers to provide reasonable break time and space other than a bathroom for breastfeeding women to express their milk. However, this law does not include students in higher education institutions who choose to breastfeed, as students are typically not employed by their schools. The purpose of this report is to describe the joint efforts of faculty members and students to successfully operationalize a lactation room and develop college-specific lactation guidelines in a university in central Kentucky.Method: Students from a college of nursing (CON) participated in a survey (N = 135), of which 30% were parenting at that time (n = 41).Results: Responses from this subset were used to make the case to CON leadership and faculty to develop college-specific guidelines entitled, “Guidelines for Lactation Support,” which was included in students’ handbooks, and to the designated space for a lactation room in the CONbuilding.Discussion: The combined effort of faculty, administrators, and students was crucial to promotea breastfeeding-friendly environment in the CON.
- 13 May 2020
- Published by Elsevier in Addictive Behaviors
- Vol. 108, 106462
ENDS use among college students: Salivary biomarkers and persistent cough
- 13 May 2020
- Published by Elsevier in Addictive Behaviors
- Vol. 108, 106462
ENDS use among college students: Salivary biomarkers and persistent cough
- 31 July 2019
- Published by Wiley in Birth Defects Research
- Vol. 111 (17) , 1284-1293
Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery
Electronic nicotine delivery systems (ENDS), which includes e‐cigarettes (ECIGs), are a rapidly‐expanding class of products that heat a liquid (which may or may not contain nicotine) to produce an aerosol. The variation of ECIG components is extensive as are their effects on users. Epidemiological data show that while both adults and youth use ECIGs, use among youth has increased dramatically in recent years. Other epidemiological data show that women of reproductive age and some pregnant women are also using ECIGs. The goal of this article is to provide readers with background information about ECIGs, with a focus on recent findings about ECIG use in pregnancy and potential implications. Among pregnant women, correlates of ECIG use include current cigarette smoking, among other factors. Regarding pregnant women's perceptions of ECIG use in pregnancy, two themes emerge from the literature: many pregnant women perceive ECIGs to be safer than conventional cigarettes, and that ECIGs can aid with smoking cessation. In contrast to these perceptions, there is little concrete evidence that ECIGs help smokers quit. In addition, there are concerns about ECIG nicotine and other toxicant delivery. Nicotine is a toxicant of particular concern for pregnant women, as nicotine is known to harm a developing fetus. There are many limitations to existing research, and the literature is scant in this area. Further, new “pod mod”‐style ECIGs such as JUUL present new challenges. Overall, with limited evidence of their effectiveness, and concerns about developmental toxicology, the authors do not recommend that pregnant women use ECIGs.
- 31 July 2019
- Published by Wiley in Birth Defects Research
- Vol. 111 (17) , 1284-1293
Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery
Electronic nicotine delivery systems (ENDS), which includes e‐cigarettes (ECIGs), are a rapidly‐expanding class of products that heat a liquid (which may or may not contain nicotine) to produce an aerosol. The variation of ECIG components is extensive as are their effects on users. Epidemiological data show that while both adults and youth use ECIGs, use among youth has increased dramatically in recent years. Other epidemiological data show that women of reproductive age and some pregnant women are also using ECIGs. The goal of this article is to provide readers with background information about ECIGs, with a focus on recent findings about ECIG use in pregnancy and potential implications. Among pregnant women, correlates of ECIG use include current cigarette smoking, among other factors. Regarding pregnant women's perceptions of ECIG use in pregnancy, two themes emerge from the literature: many pregnant women perceive ECIGs to be safer than conventional cigarettes, and that ECIGs can aid with smoking cessation. In contrast to these perceptions, there is little concrete evidence that ECIGs help smokers quit. In addition, there are concerns about ECIG nicotine and other toxicant delivery. Nicotine is a toxicant of particular concern for pregnant women, as nicotine is known to harm a developing fetus. There are many limitations to existing research, and the literature is scant in this area. Further, new “pod mod”‐style ECIGs such as JUUL present new challenges. Overall, with limited evidence of their effectiveness, and concerns about developmental toxicology, the authors do not recommend that pregnant women use ECIGs.
- 1 May 2019
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 73, 42-48
Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being
- 1 May 2019
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 73, 42-48
Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being
- 6 February 2019
- Published by SAGE Publications in Western Journal of Nursing Research
- Vol. 41 (8) , 1103-1120
Perinatal Navigator Approach to Smoking Cessation for Women With Prevalent Opioid Dependence
Women who smoke during pregnancy face psychosocial barriers to cessation, and women with opioid use disorder (OUD) face amplified barriers. We pilot tested a Perinatal Wellness Navigator (PWN) program for a group of high-risk perinatal women (N = 50; n = 42 with OUD) that consisted of (a) one-on-one tobacco treatment, (b) comprehensive assessment of cessation barriers, and (c) linkage to clinical/social services. Outcome measures were assessed at baseline and postintervention. Participants smoked 10 fewer cigarettes per day (p = .05) at postintervention and were less dependent on nicotine (p < .01). Mean postnatal depression scores (p = .03) and perceived stress (p = .03) decreased postintervention. Participants received at least one referral at baseline (n = 106 total), and 10 participants received an additional 18 referrals at postintervention to address cessation barriers. The PWN program was minimally effective in promoting total tobacco abstinence in a high-risk group of perinatal women, but participants experienced reductions in cigarettes smoked per day, nicotine dependence, stress, and depression.
- 6 February 2019
- Published by SAGE Publications in Western Journal of Nursing Research
- Vol. 41 (8) , 1103-1120
Perinatal Navigator Approach to Smoking Cessation for Women With Prevalent Opioid Dependence
Women who smoke during pregnancy face psychosocial barriers to cessation, and women with opioid use disorder (OUD) face amplified barriers. We pilot tested a Perinatal Wellness Navigator (PWN) program for a group of high-risk perinatal women (N = 50; n = 42 with OUD) that consisted of (a) one-on-one tobacco treatment, (b) comprehensive assessment of cessation barriers, and (c) linkage to clinical/social services. Outcome measures were assessed at baseline and postintervention. Participants smoked 10 fewer cigarettes per day (p = .05) at postintervention and were less dependent on nicotine (p < .01). Mean postnatal depression scores (p = .03) and perceived stress (p = .03) decreased postintervention. Participants received at least one referral at baseline (n = 106 total), and 10 participants received an additional 18 referrals at postintervention to address cessation barriers. The PWN program was minimally effective in promoting total tobacco abstinence in a high-risk group of perinatal women, but participants experienced reductions in cigarettes smoked per day, nicotine dependence, stress, and depression.
- Open Access
- 1 November 2018
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 31 (4) , 324-329
Linking Postpartum and Parenting Women With a National Diabetes Prevention Program: Recruitment Efforts, Challenges, and Recommendations
IN BRIEF Women with a history of gestational diabetes mellitus (GDM) are at higher risk for type 2 diabetes. This project piloted the National Diabetes Prevention Program lifestyle change program in cohorts of women with a history of GDM. The article describes recruitment efforts, challenges, and study participation and provides recommendations for future program implementation.
- 1 November 2018
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 31 (4) , 324-329
Open AccessLinking Postpartum and Parenting Women With a National Diabetes Prevention Program: Recruitment Efforts, Challenges, and Recommendations
IN BRIEF Women with a history of gestational diabetes mellitus (GDM) are at higher risk for type 2 diabetes. This project piloted the National Diabetes Prevention Program lifestyle change program in cohorts of women with a history of GDM. The article describes recruitment efforts, challenges, and study participation and provides recommendations for future program implementation.